Trials / Unknown
UnknownNCT04960254
Prevalence of Internet Gaming Addiction in Adolescent
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
Excessive problematic use of the internet has been a topic of discussion in the academic literature for many years and has gained more attention recently. The majority of those at risk are in early adulthood. Pathological internet use (PIU) is also termed internet addiction disorder (IAD), with both terms used to link internet use with addiction terminology. Consistent with other psychiatric conditions such as depression symptoms, PIU prevalence rates among adolescents vary widely from as low as 0.3% to 38%. Likewise, PIU prevalence among college students (young adults) showed a wide variation ranging from 3% to 34%, worldwide. Nowadays, internet gaming addiction became a problematic issue in adolescent. This is a case -control study, aimed to evaluate the prevalence and risk factors of internet gaming addiction among adolescents and its relationship with emotion regulation and comorbid psychiatric disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | internet gaming addiction | The Strengths and Difficulties Questionnaire (SDQ) parent : to asses behavioural change Socioeconomic Scale:It contains four main variables:1-The educational level of the father and mother.2-The occupation of the father and mother. 3-Total family income. 4-life style of the family. Emotional Avoidance Strategy Inventory for Adolescents (EASI):The EASIA is a 17-item (Kennedy \& Ehrenreich-May 2017) measure assessing the use of emotionally avoidant strategies in adolescents. The internet gaming addiction scale : t is used to evaluate internet gaming addiction. |
Timeline
- Start date
- 2021-12-06
- Primary completion
- 2022-01-01
- Completion
- 2022-10-01
- First posted
- 2021-07-13
- Last updated
- 2021-12-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04960254. Inclusion in this directory is not an endorsement.